Use of idraparinux for the extended prophylaxis of thromboembolism

Details for Australian Patent Application No. 2008203413 (hide)

Owner Sanofi-Aventis

Inventors Pillion, Gerard

Agent A J Park

Filing date 31 July 2008

Event Publications

14 August 2008 Complete Application Filed

7 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008203414-Methods of delivery of exogenous proteins to the cytosol and uses thereof

2008203412-Appointment Services